Genes of human longevity: An endless quest?

Current Vascular Pharmacology

Volumn 12, Issue 5, 2014, Pages 707-717

  Capri, Miriam ^a,b   Santoro, Aurelia ^a   Garagnani, Paolo ^b   Bacalini, Maria Giulia ^b   Pirazzini, Chiara ^b   Olivieri, Fabiola ^c,d   Procopio, Antonio ^c,d   Salvioli, Stefano ^a,b   Franceschi, Claudio ^a,b  

^a ALMA MATER STUDIORUM ^*  (Italy)

^b CIG   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d INRCA   (Italy)

Author keywords

APOE; ELOVL2; Epigenetics; IGF 1; Longevity; Microbiota; mtDNA; mTOR

Indexed keywords

APOLIPOPROTEIN E; DNA METHYLTRANSFERASE 1; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOCHONDRIAL DNA; SOMATOMEDIN C RECEPTOR; MTOR PROTEIN, HUMAN; SOMATOMEDIN C; TARGET OF RAPAMYCIN KINASE;

ARTICLE; ASHKENAZI JEW; CALORIC INTAKE; DNA METHYLATION; DNA REPAIR; ENERGY CONSUMPTION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROPLASMY; HUMAN; HUMAN GENETICS; INTRACELLULAR SIGNALING; LINKAGE ANALYSIS; LIOTHYRONINE BLOOD LEVEL; LIPID METABOLISM; LONGEVITY; METAGENOME; MICROFLORA; MITOCHONDRIAL GENOME; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENESCENCE; SEX CHROMOSOME; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; TELOMERE HOMEOSTASIS; AGING; GENETIC EPIGENESIS; GENETICS; METABOLISM; VERY ELDERLY;

AGED, 80 AND OVER; AGING; EPIGENESIS, GENETIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; TOR SERINE-THREONINE KINASES;

EID: 84924091788     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161111666131219110301     Document Type: Article

References (133)

1. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
2. Sebastiani P, Riva A, Montano M, et al. Whole genome sequences of a male and female supercentenarian, ages greater than 114+ years. Front Genet 2011; 2: 90-118.
3. Beekman M, Blanché H, Perola M, et al. Genome-wide linkage analysis for human longevity: Genetics of healthy ageing study. Aging Cell 2013; 12: 184-93.
4. Cevenini E, Bellavista E, Tieri P, et al. Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies. Curr Pharm Des 2010; 16: 802-13.
5. Cevenini E, Invidia L, Lescai F, et al. Human models of aging and longevity. Expert Opin Biol Ther 2008; 8: 1393-405.
6. Capri M, Salvioli S, Sevini F, et al. The genetics of human longevity. Ann N Y Acad Sci 2006; 1067: 252-63.
7. Franceschi C, Capri M, Monti D, et al. Inflamm-aging and antiinflamm-aging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128: 92-105.
8. Deelen J, Beekman M, Capri M, et al. Identifying the genomic determinants of aging and longevity in human population studies: Progress and challenges. Bioessays 2013; 35: 386-96.
9. Bonafè M, Barbieri M, Marchegiani F, et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 2003; 88: 3299-304.
10. Parrella E, Longo VD. Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain. ScientificWorldJournal 2010; 10: 161-77.
11. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science 2010; 328: 321-6.
12. Bartke A, Brown-Borg H. Life extension in the dwarf mouse. Curr Top Dev Biol 2004; 63: 189-225.
13. Ikeno Y, Hubbard GB, Lee S, et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci 2009; 64: 522-9.
14. Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012; 483: 218-21.
15. Barbieri M, Bonafe M, Franceschi C, Paolisso G. Insulin/IGFIsignaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 2003; 285: E1064-71.
16. Barbieri M, Ferrucci L, Ragno E, et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284: E481-7.
17. Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulinlike growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008; 105: 3438-42.
18. Pawlikowska L, Hu D, Huntsman S, et al. Study of Osteoporotic Fractures. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 2009; 8(4): 460-72.
19. Tazearslan C, Huang J, Barzilai N, Suh Y. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles. Aging Cell 2011; 10: 551-4.
20. Vitale G, Brugts MP, Ogliari G, et al. Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians' offspring. Aging (Albany NY) 2012; 4: 580-9.
21. Rozing MP, Westendorp RG, Frölich M, et al. Leiden Longevity Study (LLS) Group. Human insulin/IGF and familial longevity at middle age. Aging (Albany NY) 2009; 1: 714-722.
22. Soerensen M, Dato S, Tan Q, et al. Human longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studies. Exp Gerontol 2012; 47: 379-87.
23. Mariotti S, Barbesino G, Caturegli P, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993; 77: 1130-4.
24. Corsonello A, Montesanto A, Berardelli M, et al. A cross-section analysis of FT3 age-related changes in a group of old and oldestold subjects, including centenarians' relatives, shows that a down regulated thyroid function has a familial component and is related to longevity. Age Ageing 2010; 39: 723-7.
25. Rozing MP, Houwing-Duistermaat JJ, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab 2010; 95: 4979-84.
26. Rozing MP, Westendorp RG, de Craen AJ, et al. Leiden Longevity Study (LLS) Group. Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci 2010; 65: 365-8.
27. Genedani S, Filaferro M, Carone C, et al. Influence of f-MLP, ACTH(1-24) and CRH on in vitro chemotaxis of monocytes from centenarians. Neuroimmunomodulation 2008; 15: 285-9.
28. Bik W, Baranowska-Bik A, Wolinska-Witort E, et al. Assessment of adiponectin and its isoforms in Polish centenarians. Exp Gerontol 2013; 48(4): 401-7.
29. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008; 63: 447-53.
30. Bucci L, Yani SL, Fabbri C, et al. Circulating levels of adipokines and IGF-1 are associated with skeletal muscle strength of young and old healthy subjects. Biogerontology 2013, 14: 261-72.
31. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-9.
32. Wang Z, Masternak MM, Al-Regaiey KA, Bartke A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 2007; 148: 2845-53.
33. Masternak MM, Bartke A, Wang F, et al. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell 2012; 11: 73-81.
34. Weiss EP, Fontana L. Caloric restriction: powerful protection for the aging heart and vasculature. Am J Physiol Heart Circ Physiol 2011; 301: H1205-19.
35. Weiss EP, Villareal DT, Racette SB, et al. Caloric restriction but not exercise-induced reductions in fat mass decrease plasma triiodothyronine concentrations: a randomized controlled trial. Rejuvenation Res 2008; 11: 605-9.
36. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) 2010; 32: 97-108.
37. Stein PK, Soare A, Meyer TE, et al. Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell 2012; 11: 644-50.
38. Mercken EM, Crosby SD, Lamming DW, et al. Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 2013; 12: 645-51.
39. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med 2011; 3: 70ra13.
40. Di Bona D, Accardi G, Virruso C, et al. Association between genetic variations in the Insulin/Insulin-like growth factor (IGF-1) signaling pathway and longevity: a systematic review and metaanalysis. Curr Vasc Pharmacol 2014; 12(5): 674-81.
41. Barberi L, Scicchitano BM, De Rossi M, et al. Age-dependent alteration in muscle regeneration: the critical role of tissue niche. Biogerontology 2013; 14: 273-92.
42. Bjedov I, Partridge L. A longer and healthier life with TOR downregulation: genetics and drugs. Biochem Soc Trans 2011; 39: 460-465.
43. Remondini D, Salvioli S, Francesconi M, et al. Complex patterns of gene expression in human T cells during in vivo aging. Mol Biosyst. 2010; 6(10): 1983-92.
44. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
45. Weichhart T. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol Biol 2012; 821: 1-14.
46. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335: 1638-43.
47. Passtoors WM, Beekman M, Deelen J, et al. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 2012; 12: 24-31.
48. Harries LW, Fellows AD, Pilling LC, et al. Advancing age is associated with gene expression changes resembling mTOR inhibition: Evidence from two human populations. Mech Ageing Dev 2012; 133: 556-62.
49. Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet 2007; 8: 835-44.
50. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol 2011; 23: 744-55.
51. Barbieri M, Bonafè M, Rizzo MR, et al. Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity. Exp Gerontol 2004; 39: 1095-100.
52. Kolovou G, Katsiki N, Pavlidis A, et al. Ageing mechanisms and associated lipid changes. Curr Vasc Pharmacol 2014; 12(5): 682-9.
53. Milman S, Atzmon G, Crandal J, Barzilai N. Phenotypes and Genotypes of High Density Lipoprotein Cholesterol in Exceptional Longevity. Curr Vasc Pharmacol 2014; 12(5): 690-7.
54. Garasto S, Rose G, Derango F, et al. The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects. Ann Hum Genet 2003; 67(Pt 1): 54-62.
55. De Benedictis G, Carotenuto L, Carrieri G, et al. Age-related changes of the 3'APOB-VNTR genotype pool in ageing cohorts. Ann Hum Genet 1998; 62(Pt 2): 115-22.
56. Carrieri G, Bonafè M, De Luca M, et al. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet 2001; 108: 194-8.
57. Lescai F, Chiamenti AM, Codemo A, et al. An APOE haplotype associated with decreased e4 expression increases the risk of late onset alzheimer's disease. J Alzheimers Dis 2011; 24(2): 235-45.
58. Schupf N, Barral S, Perls T, et al. Apolipoprotein E and familial longevity. Neurobiol Aging 2013; 34: 1287-91.
59. Sebastiani P, Solovieff N, Dewan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS One 2012; 7: e29848.
60. Soerensen M, Dato S, Tan Q, et al. Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity. Age (Dordr) 2013; 35: 487-500.
61. Barzilai N, Atzmon G, Schechter C, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030-40.
62. Cellini E, Nacmias B, Olivieri F, et al. Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev 2005; 126: 826-8.
63. Salvioli S, Capri M, Santoro A, et al. The impact of mitochondrial DNA on human lifespan: a view from studies on centenarians. Biotechnol J 2008; 3: 740-9.
64. Chomyn A, Attardi G. mtDNA mutations in aging and apoptosis, Biochem Biophys Res Commun 2003; 304: 519-529.
65. Taylor RW, Barron MJ, Borthwick GM, et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 2003; 112: 1351-60.
66. Nekhaeva E, Bodyak ND, Kraytsberg Y, et al. Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues. Proc Natl Acad Sci USA 2002; 99: 5521-6.
67. Santoro A, Salvioli S, Raule N, et al. Mitochondrial DNA involvement in human longevity. Biochim Biophys Acta 2006; 1757: 1388-99.
68. Payne BA, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 2013; 22: 384-90.
69. Rose G, Passarino G, Scornaienchi V, et al. The mitochondrial DNA control region shows genetically correlated levels of heteroplasmy in leukocytes of centenarians and their offspring. BMC Genomics 2007; 8: 293-303.
70. Zhang J, Asin-Cayuela J, Fish J, et al. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc. Natl Acad Sci USA 2003; 100: 1116-21.
71. Niemi AK, Hervonen A, Hurme M, et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2003; 112: 29-33.
72. Niemi AK, Moilanen JS, Tanaka M, et al. A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 2005; 13: 166-170.
73. Rose G, Romeo G, Dato S, et al. Genetics of healthy ageing project consortium. Somatic point mutations in mtDNA control region are influenced by genetic background and associated with healthy aging: a GEHA study. PLoS One. 2010; 5: e13395.
74. Raule N, Sevini F, Lib S, et al. The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, does matter for human longevity and is population specific. Ageing Cell 2014; 13(3): 401-7.
75. Merriwether DA, Clark AG, Ballinger SW, et al. The structure of human mitochondrial DNA variation, J Mol Evol 1991; 33: 543-55.
76. Torroni A, Achilli A, Macaulay V, Richards M, Bandelt HJ. Harvesting the fruit of the human mtDNA tree. Trends Genet 2006; 22: 339-45.
77. Ruiz-Pesini E, Mishmar D, Brandon M, et al. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 2004; 303: 223-6.
78. Kivisild T, Shen P, Wall DP, et al. The role of selection in the evolution of human mitochondrial genomes. Genetics 2006: 172: 373-87.
79. De Benedictis G, Rose G, Carrieri G, et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 1999; 13: 1532-36.
80. Bilal E, Rabadan R, Alexe G, et al. Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan. PLoS One 2008; 11: e2421.
81. Chen A, Raule N, Chomyn A, Attardi G. Decreased reactive oxygen species production in cells with mitochondrial haplogroups associated with longevity. PLoS One 2012; 7: e46473.
82. Pinós T, Nogales-Gadea G, Ruiz JR, et al. Are mitochondrial haplogroups associated with extreme longevity? A study on a Spanish cohort. Age (Dordr) 2012; 34: 227-33.
83. Yang X, Wang X, Yao H, et al. Mitochondrial DNA polymorphisms are associated with the longevity in the Guangxi Bama population of China. Mol Biol Rep 2012; 39: 9123-31.
84. Feng J, Zhang J, Liu M, et al. Association of mtDNA haplogroup F with healthy longevity in the female Chuang population, China. Exp Gerontol 2011; 46(12): 987-93.
85. Fuku N, Park KS, Yamada Y, et al. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet 2007; 80: 407-415.
86. Achilli A, Olivieri A, Pala M, et al. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS One 2011; 6: e21029.
87. Gaweda-Walerych K, Maruszak A, Safranow K, et al. Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort. J Neural Transm 2008; 115: 1521-26.
88. Santoro A, Balbi V, Balducci E, et al. Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset alzheimer's disease. PLoS One 2010; 5: e12037.
89. Ridge PG, Maxwell TJ, Corcoran CD, et al. Mitochondrial Genomic Analysis of Late Onset alzheimer's Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging. PLoS One 2012; 7(9): e45134.
90. De Benedictis G, Carotenuto L, Carrieri G, et al. Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet 1998; 6: 534-541.
91. Bonafé M, Barbi C, Olivieri F, et al. An allele of HRAS1 3'variable number of tandem repeats is a frailty allele: implication for an evolutionarily-conserved pathway involved in longevity. Gene 2002; 286: 121-6.
92. van Der Walt JM, Dementieva G, Martin ER, et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neuroscience Lett 2004; 365: 28-32.
93. Roubertoux PL, Sluyter F, Carlier M, et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat Genet 2003; 35: 65-9.
94. Sharpley MS, Marciniak C, Eckel-Mahan K, et al. Heteroplasmy of Mouse mtDNA Is Genetically Unstable and Results in Altered Behavior and Cognition. Cell 2012; 151: 333-43.
95. Rand DM, Fry A, Sheldahl L. Nuclear-mitochondrial epistasis and Drosophila aging: introgression of Drosophila simulans mtDNA modifies longevity in D. melanogaster nuclear backgrounds. Genetics 2006; 172: 329-41.
96. Tranah GJ. Mitochondrial-nuclear epistasis: implications for human aging and longevity. Ageing Res Rev 2011; 10: 238-52.
97. Bellizzi D, Cavalcante P, Taverna D, et al. Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells 2006; 11: 883-91.
98. D'Aquila P, Rose G, Panno ML, et al. SIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stress. Gene 2012; 497: 323-9.
99. Bellizzi D, D'Aquila P, Giordano M, et al. Global DNA methylation levels are modulated by mitochondrial DNA variants. Epigenomics 2012; 4(1): 17-27.
100. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007; 76: 75-100.
101. Swigut T, Wysocka J. H3K27 demethylases, at long last. Cell 2007; 131: 29-32.
102. Garagnani P, Bacalini MG, Pirazzini C, et al. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell 2012; 11: 1132-4.
103. Heyn H, Li N, Ferreira HJ, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci USA 2012; 109(26): 10522-7.
104. Gentilini D, Mari D, Castaldi D, et al. Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) 2013; 35: 1961-73.
105. Gueresi P, Miglio R, Monti D, et al. Does the longevity of one or both parents influence the health status of their offspring? Exp Gerontol 2013; 48(4): 395-400.
106. Balistreri CR, Accardi G, Buffa S, et al. Centenarian Offspring: a model for Understanding Longevity. Current Vasc Pharmacol 2014; 12(5): 718-25.
107. Gentilini D, Castaldi D, Mari D, et al. Age-dependent skewing of X chromosome inactivation appears delayed in centenarians' offspring. Is there a role for allelic imbalance in healthy aging and longevity? Aging Cell 2012; 11: 277-83.
108. Bagnara GP, Bonsi L, Strippoli P, et al. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci 2000; 55: B61-6.
109. Olivieri F, Rippo MR, Monsurro V, et al. MicroRNAs linking inflamm-aging; cellular senescence and cancer. Ageing Res Rev 2013; pii: S1568-1637(13)00023-8. [Epub ahead of print].
110. Olivieri F, Spazzafumo L, Santini G, et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflamm-aging. Mech Ageing Dev 2012; 133(11-12): 675-85.
111. Fabbri M, Paone A, Calore F, Galli R, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012; 109(31): E2110-6.
112. Kim YJ, Hwang SH, Cho HH, et al. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol 2012; 227: 183-93.
113. Cevenini E, Caruso C, Candore G, et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des 2010; 16: 609-18.
114. Franceschi C, Bonafè M, Valensin S, Olivieri F, et al. Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-54.
115. Serna E, Gambini J, Borras C, et al. Centenarians, but not octogenarians, up-regulate the expression of microRNAs. Sci Rep 2012; 2: 961.
116. Gombar S, Jung HJ, Dong F, et al. Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics 2012; 13(1): 353.
117. Shock LS, Thakkar PV, Peterson EJ, et al. DNA methyltransferase 1, cytosine methyla-tion and cytosine hydroxymethylation in mammalian mitochondria. PNAS 2011; 108: 3630-5.
118. Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941-53.
119. Minocherhomji S, Tollefsbol TO, Singh KK. Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics 2012; 7: 326-34.
120. Smiraglia DJ, Kulawiec M, Bistulfi GL, et al. A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther 2008; 7: 1182-90.
121. Biagi E, Candela M, Fairweather-Tait S, et al. Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 2012; 34: 247-67.
122. Biagi E, Candela M, Franceschi C, Brigidi P. The aging gut microbiota: new perspectives. Ageing Res Rev 2011; 10(4): 428-9.
123. Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-30.
124. Kamada N, Seo S, Chen GY, Gabriel Núñez. Role of the gut microbiota in immunity and inflammatory disease. Nature Rev Immunol 2013; 13: 321-35.
125. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36: 305-12.
126. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5(5): e10667.
127. Cevenini E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care 2013; 16: 14-20.
128. Vasto S, Di Carlo M, Caruso C, Panotopoulos G. Mediterranean diet and longevity: an example of nutraceuticals? Current Vasc Pharmacol 2014; 12(5): 735-8.
129. Kolovou G, Barzilai N, Caruso C, et al. The Challenges in Moving from Ageing to Successful Longevity. Current Vasc Pharmacol 2014; 12(5): 662-73.
130. Garagnani P, Giuliani PC, et al. Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: A proof of principle on type 2 diabetes. Aging 2013; 5(5): 373-85.
131. Balistreri CR, Candore G, Accardi G, et al. Genetics of longevity: data from the studies on Sicilian centenarians. Immun Ageing 2012; 9(1): 8.
132. Sikora E, Bielak-Zmijewska A, Mosieniak G. Cellular senescence in ageing, age-related disease and longevity. Current Vasc Pharmacol 2014; 12(5): 698-706.
133. Tzanetakou IP, Nzietchueng R, Perrea DN, Benetos A. Telomeres and their role in aging and longevity. Curr Vasc Pharmacol 2014; 12(5): 726-34.